IceCure Medical (ICCM) Change in Account Payables (2020 - 2026)
IceCure Medical's (ICCM) quarterly Change in Account Payables came in at $125000.0 in Q1 2026, up 144.8% year-on-year from $51061.5 in Q1 2025, and up 143.4% on a QoQ basis from -$288000.0 in Q4 2025.
IceCure Medical (ICCM) Change in Account Payables (2020 - 2026) Analysis & Trends
IceCure Medical (ICCM) has 7 years of Change in Account Payables data on file, last reported at $125000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 144.8% year-over-year to $125000.0 in Q1 2026; TTM through Mar 2026 was $35000.0, a 88.14% decrease from a year earlier, with the FY2025 full-year figure at -$369000.0, down 150.55% from the prior year.
- Change in Account Payables for Q1 2026 stood at $125000.0, up from -$288000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for ICCM reached as high as $554000.0 in Q3 2024 and fell as low as -$627000.0 in Q4 2023.
- Historically, Change in Account Payables has averaged $6294.1 across 5 years, with a median of -$10000.0 in 2025.
- Across the five-year window, Change in Account Payables soared 637.93% in 2024 and plunged 1594.12% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $112000.0 in 2022, then slumped by 659.82% to -$627000.0 in 2023, then soared by 97.29% to -$17000.0 in 2024, then plunged by 1594.12% to -$288000.0 in 2025, then jumped by 143.4% to $125000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $125000.0 in Q1 2026, -$288000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | IceCure Medical | 7.92 Mn | -193,612.29 | 295,000.00 | 125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,000.00 |
| Mar 31, 2026 | 125,000.00 |
| Dec 31, 2025 | -288,000.00 |
| Dec 31, 2025 | -288,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | -279,000.00 |
| Mar 31, 2025 | -279,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Sep 30, 2024 | 554,000.00 |
| Sep 30, 2024 | 554,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | -627,000.00 |
| Dec 31, 2023 | -627,000.00 |